Lymphocyte transformation observed in sulfamylon agranulocytosis.
D000380:Agranulocytosis / Q000139:chemically induced*; D001853:Bone Marrow / Q000473:pathology / Q000503:physiopathology; D002056:Burns / Q000150:complications / Q000188:drug therapy / Q000601:surgery; D004247:DNA / Q000096:biosynthesis; D003864:Depression, Chemical; D006801:Humans; D007223:Infant; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology*; D008297:Male; D009824:Ointments / Q000009:adverse effects; D016038:Skin Transplantation; D013449:Sulfonamides / Q000009:adverse effects* / Q000378:metabolism; D013936:Thymidine / Q000378:metabolism; D014050:Toluene / Q000009:adverse effects / Q000378:metabolism; D014182:Transplantation, Autologous
D009824:Ointments; D013449:Sulfonamides; D014050:Toluene; D004247:DNA; D013936:Thymidine